Roche's Venclexta failure does not affect the oncology pipeline, as HER2 franchise continues to drive revenue growth. Click ...

The first patient enrolled in a planned international clinical trial has been treated at HonorHealth Research Institute with a new type of immune therapy for those with a rare muscle-weakness disease ...

Bacteria carry countless hidden treasures in their DNA—fragments that could hold the key to new medicines. But how do you ...

Powerful llama-derived antibodies could be the key to stopping not just current SARS viruses, but future ones too. Scientists ...